Pfizer is paying $1.25 billion to join the PD-(L1)xVEGF bispecific race. | Pfizer is paying $1.25 billion to join the ...

WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People’s Republic of China, North America, Europe, and ...

Samsung Biologics Co., the world’s largest contract drugmaker, said on Thursday it has signed an initial agreement with LigaChem Biosciences Inc., a South Korean biotech startup, to jointly develop ...

Samsung Biologics Co., the world’s largest contract manufacturing organization (CMO), said on Monday it has secured a $5.14 million order from a US pharmaceutical company. Analysts expect the latest ...

The Global Biologics CDMO Market is expected to witness a growth rate of 14-16% in the next five years. Growing ...

This is the second year that WuXi XDC has participated in the Extel ranking and won multiple awards. With its outstanding ...

China NMPA grants marketing approval to CANbridge’s velaglucerase-beta for injection to trat Type I and III Gaucher disease: Suzhou, China Monday, May 19, 2025, 14:00 Hrs [IST] ...